APO Research
Talk to an analyst

APO RESEARCH · REPORT

Autoimmune Disease Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Autoimmune Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchAutoimmune Disease Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Autoimmune Disease Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Autoimmune Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autoimmune Disease Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Autoimmune Disease Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Autoimmune Disease Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Autoimmune Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Autoimmune Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Autoimmune Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Autoimmune Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Autoimmune Disease Drug include Roche, Eli Lilly, Pfizer, GlaxoSmithKline, Amgen, AbbVie, Bristol-Myers Squibb, Biogen and AstraZeneca plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Autoimmune Disease Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Autoimmune Disease Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Autoimmune Disease Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Autoimmune Disease Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Autoimmune Disease Drug Segment by Company

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

Amgen

AbbVie

Bristol-Myers Squibb

Biogen

AstraZeneca plc

Abbott Laboratories

Autoimmune Disease Drug Segment by Type

NSAIDs

Interferons

Antihyperglycemics

Anti-Inflammatory

Others

Autoimmune Disease Drug Segment by Application

Psoriasis

Inflammatory Bowel Disease

Rheumatoid Arthritis

Lupus

Multiple Sclerosis

Type 1 Diabetes

Others

Autoimmune Disease Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autoimmune Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autoimmune Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autoimmune Disease Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Autoimmune Disease Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Autoimmune Disease Drug industry.

Chapter 3: Detailed analysis of Autoimmune Disease Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autoimmune Disease Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Autoimmune Disease Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of NSAIDs Table 3. Key Players of Interferons Table 4. Key Players of Antihyperglycemics Table 3. Key Players of Anti-Inflammatory Table 4. Key Players of Others Table 5. Global Autoimmune Disease Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Psoriasis Table 7. Key Players of Inflammatory Bowel Disease Table 8. Key Players of Rheumatoid Arthritis Table 9. Key Players of Lupus Table 10. Key Players of Multiple Sclerosis Table 11. Key Players of Type 1 Diabetes Table 12. Key Players of Others Table 13. Global Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Autoimmune Disease Drug Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Autoimmune Disease Drug Market Share by Region (2021-2026) Table 16. Global Autoimmune Disease Drug Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Autoimmune Disease Drug Market Share by Region (2027-2032) Table 18. Autoimmune Disease Drug Industry Trends Table 19. Autoimmune Disease Drug Industry Drivers Table 20. Autoimmune Disease Drug Industry Opportunities and Challenges Table 21. Autoimmune Disease Drug Industry Restraints Table 22. Global Autoimmune Disease Drug Revenue by Company (US$ Million) & (2021-2026) Table 23. Global Autoimmune Disease Drug Revenue Market Share by Company (2021-2026) Table 24. Global Autoimmune Disease Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 25. Global Autoimmune Disease Drug Key Company Head Office and Area Served Table 26. Global Autoimmune Disease Drug Company, Product Type & Application Table 27. Global Autoimmune Disease Drug Company Establishment Date Table 28. Global Company Market Concentration Ratio (CR5 and HHI) Table 29. Global Autoimmune Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 30. Global Autoimmune Disease Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Autoimmune Disease Drug Market Size by Type (2021-2026) & (US$ Million) Table 32. Global Autoimmune Disease Drug Market Size by Type (2027-2032) & (US$ Million) Table 33. Global Autoimmune Disease Drug Revenue Market Share by Type (2021-2026) Table 34. Global Autoimmune Disease Drug Revenue Market Share by Type (2027-2032) Table 35. Global Autoimmune Disease Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Autoimmune Disease Drug Market Size by Application (2021-2026) & (US$ Million) Table 37. Global Autoimmune Disease Drug Market Size by Application (2027-2032) & (US$ Million) Table 38. Global Autoimmune Disease Drug Revenue Market Share by Application (2021-2026) Table 39. Global Autoimmune Disease Drug Revenue Market Share by Application (2027-2032) Table 40. Roche Company Information Table 41. Roche Business Overview Table 42. Roche Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Roche Autoimmune Disease Drug Product Portfolio Table 44. Roche Recent Development Table 45. Eli Lilly Company Information Table 46. Eli Lilly Business Overview Table 47. Eli Lilly Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Eli Lilly Autoimmune Disease Drug Product Portfolio Table 49. Eli Lilly Recent Development Table 50. Pfizer Company Information Table 51. Pfizer Business Overview Table 52. Pfizer Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Pfizer Autoimmune Disease Drug Product Portfolio Table 54. Pfizer Recent Development Table 55. GlaxoSmithKline Company Information Table 56. GlaxoSmithKline Business Overview Table 57. GlaxoSmithKline Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. GlaxoSmithKline Autoimmune Disease Drug Product Portfolio Table 59. GlaxoSmithKline Recent Development Table 60. Amgen Company Information Table 61. Amgen Business Overview Table 62. Amgen Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Amgen Autoimmune Disease Drug Product Portfolio Table 64. Amgen Recent Development Table 65. AbbVie Company Information Table 66. AbbVie Business Overview Table 67. AbbVie Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. AbbVie Autoimmune Disease Drug Product Portfolio Table 69. AbbVie Recent Development Table 70. Bristol-Myers Squibb Company Information Table 71. Bristol-Myers Squibb Business Overview Table 72. Bristol-Myers Squibb Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Bristol-Myers Squibb Autoimmune Disease Drug Product Portfolio Table 74. Bristol-Myers Squibb Recent Development Table 75. Biogen Company Information Table 76. Biogen Business Overview Table 77. Biogen Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Biogen Autoimmune Disease Drug Product Portfolio Table 79. Biogen Recent Development Table 80. AstraZeneca plc Company Information Table 81. AstraZeneca plc Business Overview Table 82. AstraZeneca plc Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. AstraZeneca plc Autoimmune Disease Drug Product Portfolio Table 84. AstraZeneca plc Recent Development Table 85. Abbott Laboratories Company Information Table 86. Abbott Laboratories Business Overview Table 87. Abbott Laboratories Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Abbott Laboratories Autoimmune Disease Drug Product Portfolio Table 89. Abbott Laboratories Recent Development Table 90. North America Autoimmune Disease Drug Market Size by Type (2021-2026) & (US$ Million) Table 91. North America Autoimmune Disease Drug Market Size by Type (2027-2032) & (US$ Million) Table 92. North America Autoimmune Disease Drug Market Size by Application (2021-2026) & (US$ Million) Table 93. North America Autoimmune Disease Drug Market Size by Application (2027-2032) & (US$ Million) Table 94. North America Autoimmune Disease Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Autoimmune Disease Drug Market Size by Country (2021-2026) Table 96. North America Autoimmune Disease Drug Market Size by Country (2027-2032) Table 97. Europe Autoimmune Disease Drug Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe Autoimmune Disease Drug Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe Autoimmune Disease Drug Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe Autoimmune Disease Drug Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe Autoimmune Disease Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Autoimmune Disease Drug Market Size by Country (2021-2026) Table 103. Europe Autoimmune Disease Drug Market Size by Country (2027-2032) Table 104. China Autoimmune Disease Drug Market Size by Type (2021-2026) & (US$ Million) Table 105. China Autoimmune Disease Drug Market Size by Type (2027-2032) & (US$ Million) Table 106. China Autoimmune Disease Drug Market Size by Application (2021-2026) & (US$ Million) Table 107. China Autoimmune Disease Drug Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Autoimmune Disease Drug Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia Autoimmune Disease Drug Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia Autoimmune Disease Drug Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia Autoimmune Disease Drug Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Autoimmune Disease Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Autoimmune Disease Drug Market Size by Country (2021-2026) Table 114. Asia Autoimmune Disease Drug Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa Autoimmune Disease Drug Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Autoimmune Disease Drug Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Autoimmune Disease Drug Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Autoimmune Disease Drug Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Autoimmune Disease Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa Autoimmune Disease Drug Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa Autoimmune Disease Drug Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Autoimmune Disease Drug Product Image Figure 2. Global Autoimmune Disease Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Autoimmune Disease Drug Market Share by Type: 2025 VS 2032 Figure 4. NSAIDs Image Figure 5. Interferons Image Figure 6. Antihyperglycemics Image Figure 7. Anti-Inflammatory Image Figure 8. Others Image Figure 9. Global Autoimmune Disease Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Autoimmune Disease Drug Market Share by Application: 2025 VS 2032 Figure 11. Psoriasis Image Figure 12. Inflammatory Bowel Disease Image Figure 13. Rheumatoid Arthritis Image Figure 14. Lupus Image Figure 15. Multiple Sclerosis Image Figure 16. Type 1 Diabetes Image Figure 17. Others Image Figure 18. Global Autoimmune Disease Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 20. Global Autoimmune Disease Drug Market Share by Region: 2025 VS 2032 Figure 21. Years Considered Figure 22. Global Autoimmune Disease Drug Market Share by Players in 2025 Figure 23. Global Top 5 and 10 Autoimmune Disease Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Autoimmune Disease Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Autoimmune Disease Drug Revenue Market Share by Type (2021-2032) Figure 27. Global Autoimmune Disease Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Autoimmune Disease Drug Revenue Market Share by Application (2021-2032) Figure 29. North America Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 30. North America Autoimmune Disease Drug Market Share by Type (2021-2032) Figure 31. North America Autoimmune Disease Drug Market Share by Application (2021-2032) Figure 32. North America Autoimmune Disease Drug Market Share by Country (2021-2032) Figure 33. United States Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 34. Canada Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 35. Mexico Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 36. Europe Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 37. Europe Autoimmune Disease Drug Market Share by Type (2021-2032) Figure 38. Europe Autoimmune Disease Drug Market Share by Application (2021-2032) Figure 39. Europe Autoimmune Disease Drug Market Share by Country (2021-2032) Figure 40. Germany Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 41. France Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 42. U.K. Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 43. Italy Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 44. Russia Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 45. Nordic Countries Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 46. China Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 47. China Autoimmune Disease Drug Market Share by Type (2021-2032) Figure 48. China Autoimmune Disease Drug Market Share by Application (2021-2032) Figure 49. Asia Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 50. Asia Autoimmune Disease Drug Market Share by Type (2021-2032) Figure 51. Asia Autoimmune Disease Drug Market Share by Application (2021-2032) Figure 52. Asia Autoimmune Disease Drug Market Share by Country (2021-2032) Figure 53. Japan Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 54. South Korea Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 55. Taiwan Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 56. Southeast Asia Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 57. India Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 58. Australia Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 60. South America, Middle East & Africa Autoimmune Disease Drug Market Share by Type (2021-2032) Figure 61. South America, Middle East & Africa Autoimmune Disease Drug Market Share by Application (2021-2032) Figure 62. South America, Middle East & Africa Autoimmune Disease Drug Market Share by Country (2021-2032) Figure 63. Brazil Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 64. South Africa Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 65. Saudi Arabia Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 66. Turkey Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 67. Argentina Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 68. UAE Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 69. Egypt Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 70. Chile Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • NSAIDs
  • Interferons
  • Antihyperglycemics
  • Anti-Inflammatory
  • Others
Applications
  • Psoriasis
  • Inflammatory Bowel Disease
  • Rheumatoid Arthritis
  • Lupus
  • Multiple Sclerosis
  • Type 1 Diabetes
  • Others
Companies covered
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Amgen
  • AbbVie
  • Bristol-Myers Squibb
  • Biogen
  • AstraZeneca plc
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Autoimmune Disease Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 NSAIDs
  5. 1.2.3 Interferons
  6. 1.2.4 Antihyperglycemics
  7. 1.2.5 Anti-Inflammatory
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Autoimmune Disease Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Psoriasis
  12. 1.3.3 Inflammatory Bowel Disease
  13. 1.3.4 Rheumatoid Arthritis
  14. 1.3.5 Lupus
  15. 1.3.6 Multiple Sclerosis
  16. 1.3.7 Type 1 Diabetes
  17. 1.3.8 Others
  18. 1.4 Global Market Growth Prospects
  19. 1.5 Global Autoimmune Disease Drug Growth Trends by Region
  20. 1.5.1 Global Autoimmune Disease Drug Market Size by Region: 2021 VS 2025 VS 2032
  21. 1.5.2 Autoimmune Disease Drug Market Size by Region (2021-2026)
  22. 1.5.3 Autoimmune Disease Drug Market Size by Region (2027-2032)
  23. 1.6 Assumptions and Limitations
  24. 1.7 Study Goals and Objectives
  25. 1.8 Years Considered
2 Global Autoimmune Disease Drug Market Dynamics
  1. 2.1 Autoimmune Disease Drug Industry Trends
  2. 2.2 Autoimmune Disease Drug Industry Drivers
  3. 2.3 Autoimmune Disease Drug Industry Opportunities and Challenges
  4. 2.4 Autoimmune Disease Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Autoimmune Disease Drug Revenue by Company (2021-2026)
  2. 3.2 Global Autoimmune Disease Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Autoimmune Disease Drug Key Company Head office and Area Served
  4. 3.4 Global Autoimmune Disease Drug Company, Product Type & Application
  5. 3.5 Global Autoimmune Disease Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Autoimmune Disease Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Autoimmune Disease Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Autoimmune Disease Drug Tier 1, Tier 2, and Tier 3
4 Autoimmune Disease Drug Market by Type
  1. 4.1 Global Autoimmune Disease Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Autoimmune Disease Drug Market Size by Type (2021-2032)
  3. 4.3 Global Autoimmune Disease Drug Market Size Share by Type (2021-2032)
5 Autoimmune Disease Drug Market by Application
  1. 5.1 Global Autoimmune Disease Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Autoimmune Disease Drug Market Size by Application (2021-2032)
  3. 5.3 Global Autoimmune Disease Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Roche Autoimmune Disease Drug Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eli Lilly Autoimmune Disease Drug Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pfizer Autoimmune Disease Drug Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 GlaxoSmithKline Autoimmune Disease Drug Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 Amgen
  26. 6.5.1 Amgen Company Information
  27. 6.5.2 Amgen Business Overview
  28. 6.5.3 Amgen Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Amgen Autoimmune Disease Drug Product Portfolio
  30. 6.5.5 Amgen Recent Developments
  31. 6.6 AbbVie
  32. 6.6.1 AbbVie Company Information
  33. 6.6.2 AbbVie Business Overview
  34. 6.6.3 AbbVie Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 AbbVie Autoimmune Disease Drug Product Portfolio
  36. 6.6.5 AbbVie Recent Developments
  37. 6.7 Bristol-Myers Squibb
  38. 6.7.1 Bristol-Myers Squibb Company Information
  39. 6.7.2 Bristol-Myers Squibb Business Overview
  40. 6.7.3 Bristol-Myers Squibb Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Bristol-Myers Squibb Autoimmune Disease Drug Product Portfolio
  42. 6.7.5 Bristol-Myers Squibb Recent Developments
  43. 6.8 Biogen
  44. 6.8.1 Biogen Company Information
  45. 6.8.2 Biogen Business Overview
  46. 6.8.3 Biogen Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Biogen Autoimmune Disease Drug Product Portfolio
  48. 6.8.5 Biogen Recent Developments
  49. 6.9 AstraZeneca plc
  50. 6.9.1 AstraZeneca plc Company Information
  51. 6.9.2 AstraZeneca plc Business Overview
  52. 6.9.3 AstraZeneca plc Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 AstraZeneca plc Autoimmune Disease Drug Product Portfolio
  54. 6.9.5 AstraZeneca plc Recent Developments
  55. 6.10 Abbott Laboratories
  56. 6.10.1 Abbott Laboratories Company Information
  57. 6.10.2 Abbott Laboratories Business Overview
  58. 6.10.3 Abbott Laboratories Autoimmune Disease Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Abbott Laboratories Autoimmune Disease Drug Product Portfolio
  60. 6.10.5 Abbott Laboratories Recent Developments
7 North America
  1. 7.1 North America Autoimmune Disease Drug Market Size (2021-2032)
  2. 7.2 North America Autoimmune Disease Drug Market Size by Type
  3. 7.2.1 North America Autoimmune Disease Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Autoimmune Disease Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Autoimmune Disease Drug Market Share by Type (2021-2032)
  6. 7.3 North America Autoimmune Disease Drug Market Size by Application
  7. 7.3.1 North America Autoimmune Disease Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Autoimmune Disease Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Autoimmune Disease Drug Market Share by Application (2021-2032)
  10. 7.4 North America Autoimmune Disease Drug Market Size by Country
  11. 7.4.1 North America Autoimmune Disease Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Autoimmune Disease Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Autoimmune Disease Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Autoimmune Disease Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Autoimmune Disease Drug Market Size (2021-2032)
  2. 8.2 Europe Autoimmune Disease Drug Market Size by Type
  3. 8.2.1 Europe Autoimmune Disease Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Autoimmune Disease Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Autoimmune Disease Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Autoimmune Disease Drug Market Size by Application
  7. 8.3.1 Europe Autoimmune Disease Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Autoimmune Disease Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Autoimmune Disease Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Autoimmune Disease Drug Market Size by Country
  11. 8.4.1 Europe Autoimmune Disease Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Autoimmune Disease Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Autoimmune Disease Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Autoimmune Disease Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Autoimmune Disease Drug Market Size (2021-2032)
  2. 9.2 China Autoimmune Disease Drug Market Size by Type
  3. 9.2.1 China Autoimmune Disease Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Autoimmune Disease Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Autoimmune Disease Drug Market Share by Type (2021-2032)
  6. 9.3 China Autoimmune Disease Drug Market Size by Application
  7. 9.3.1 China Autoimmune Disease Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Autoimmune Disease Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Autoimmune Disease Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Autoimmune Disease Drug Market Size (2021-2032)
  2. 10.2 Asia Autoimmune Disease Drug Market Size by Type
  3. 10.2.1 Asia Autoimmune Disease Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Autoimmune Disease Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Autoimmune Disease Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Autoimmune Disease Drug Market Size by Application
  7. 10.3.1 Asia Autoimmune Disease Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Autoimmune Disease Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Autoimmune Disease Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Autoimmune Disease Drug Market Size by Country
  11. 10.4.1 Asia Autoimmune Disease Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Autoimmune Disease Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Autoimmune Disease Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Autoimmune Disease Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Autoimmune Disease Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Autoimmune Disease Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Autoimmune Disease Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Autoimmune Disease Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Autoimmune Disease Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Autoimmune Disease Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Autoimmune Disease Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Autoimmune Disease Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Autoimmune Disease Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Autoimmune Disease Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Autoimmune Disease Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Autoimmune Disease Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Autoimmune Disease Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Autoimmune Disease Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst